https://www.selleckchem.com/pr....oducts/sodium-2-1h-i
Models that can predict brain amyloid beta (Aβ) status more accurately have been desired to identify participants for clinical trials of preclinical Alzheimer's disease (AD). However, potential heterogeneity between different cohorts and the limited cohort size have been the reasons preventing the development of reliable models applicable to the Asian population, including Japan. We aim to propose a novel approach to predict preclinical AD while overcoming these constraints, by building models specifically optimize
Like
Comment
Share
